Biotech Market Research – Different Approach To Stay Ahead Of Your Competitor

  (Albany, US) DelveInsight has launched a new report on " Primary Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030 " . DelveInsight's " Primary Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Primary Biliary Cirrhosis, historical and forecasted epidemiology as well as the Primary Biliary Cirrhosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the Companies: ·          According to American Association for the Study of Liver Diseases (AASLD), in 2016, the prevalence of PBC in the U.S. was estimated to vary from 1.91 to 40.2 per 100,000 persons ·          In UK, the prevalence of PBC is estimated to be 12.9 per 100,000 population, of which 90% of cases where reported in women ·          Epidemiological studies also revealed the prevalence of PBC to be around 27–54 per million cases

    (Albany, US) DelveInsight has launched a new report on " Pruritus - Market Insights, Epidemiology, and Market Forecast-2030 ". DelveInsight's " Pruritus - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Pruritus, historical and forecasted epidemiology as well as the Pruritus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the Facts: ·          A 2013 study by Shive et al. reported 77 million visits for itch in America over an 11-year period, with an average of 7 million visits per year, accounting for roughly 1 % of all physician visits. ·          According to the study published by Nicholas et al., the prevalence of pruritus in the general population varies from 8 to 38 % worldwide. ·          The study published by Laurent et al., suggested that in the database maintained by the Münster Competence Centre of Chronic Pruritu

  (Albany, US) DelveInsight has launched a new report on " Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030 " . DelveInsight's " Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the contents: ·          According to National Psoriasis Foundation (NPF), more than 8 million Americans have psoriasis. Plaque psoriasis is the most common form of the disease, affecting 80 percent of those with psoriasis. ·          In U.S., the prevalence of Psoriasis is estimated to be 0.6 to 4.8%. ·          125 million people worldwide which is about 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium. ·          Accord

  (Albany, US) DelveInsight has launched a new report on " Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology, and Market Forecast-2030 " . DelveInsight's " Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the facts: ·          As per the National Multiple Sclerosis Society, about 15% of the total estimated MS patients in the United States with multiple sclerosis (MS) have the primary progressive form of the disease (PPMS). ·          According to a study by Costa-Arpín et al. (2020), in a Spanish cohort, 71.17% had relapsing-remitting MS, 16.55% secondary progressive

(Albany, US) DelveInsight has launched a new report on " Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030 ". DelveInsight's " Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Optic Neuritis, historical and forecasted epidemiology as well as the Optic Neuritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the facts: ·          A rare condition with an estimated annual incidence of 6.4 per 100,000 cases in population in the United States. ·          ON is most common among adults, age 20 to 40 years, and its symptoms generally improve in 80 percent of patients over few weeks. ·          More females are affected than males and approximately five out of every one-hundred thousand people are affected by ON every year View Report: https://www.delveinsight.com/report-store/optic-neuritis-market Request for

  (Albany, US) DelveInsight has launched a new report on " Opioid-Induced Constipation - Market Insights, Epidemiology, and Market Forecast-2030 " . DelveInsight's " Opioid-Induced Constipation - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Opioid-Induced Constipation, historical and forecasted epidemiology as well as the Opioid-Induced Constipation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Companies covered : AstraZeneca Plc Bausch Health Companies Inc. Daiichi Sankyo Co. Ltd. Ironwood Pharmaceuticals Inc. Mallinckrodt Plc Merck & Co. Inc. Novartis AG Pfizer Inc. SHIONOGI Co. Ltd. Takeda Pharmaceutical Co. Ltd View Report: https://www.delveinsight.com/report-store/opioid-induced-constipation-market Request free Sample: https://www.delveinsight.com/report-s